Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Stone

Showing results (81-90 of 420) with videos related to

Pageof 42
Sort By:
British Journal of Haematology|February 26, 2016
Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromesGregory A Abel, Angel M Cronin, Oreofe O Odejide, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2015
Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemiaOlga K Weinberg, Olga Pozdnyakova, Federico Campigotto, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Discovery of a Highly Potent and Selective Indenoindolone Type 1 Pan-FLT3 InhibitorJohn M Hatcher, Ellen Weisberg, Taebo Sim, et al.
Statistics in Medicine|July 6, 2022
Controlled variable selection in Weibull mixture cure models for high-dimensional dataHan Fu, Deedra Nicolet, Krzysztof Mrózek, et al.
Blood|October 22, 2003
Fatal hepatic necrosis following imatinib mesylate therapyNancy U Lin, Stefanie Sarantopoulos, James R Stone, et al.
Blood Reviews|February 22, 2023
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDSStacey M Frumm, Shai Shimony, Richard M Stone, et al.
Journal of Oncology Practice|August 15, 2013
Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical centerBrett E Glotzbecker, Deborah S Yolin-Raley, Daniel J DeAngelo, et al.
Clinical Trials (London, England)|July 24, 2018
Application of multi-state models in cancer clinical trialsJennifer G Le-Rademacher, Ryan A Peterson, Terry M Therneau, et al.
Briefings in Bioinformatics|October 2, 2022
High-dimensional genomic feature selection with the ordered stereotype logit modelAnna Eames Seffernick, Krzysztof Mrózek, Deedra Nicolet, et al.
Blood Advances|June 8, 2019
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)Jun Yin, Betsy LaPlant, Geoffrey L Uy, et al.
Pageof 42

Showing results (81-90 of 420) with videos related to

Sort By:
Pageof 42
British Journal of Haematology|February 26, 2016
Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromesGregory A Abel, Angel M Cronin, Oreofe O Odejide, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2015
Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemiaOlga K Weinberg, Olga Pozdnyakova, Federico Campigotto, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Discovery of a Highly Potent and Selective Indenoindolone Type 1 Pan-FLT3 InhibitorJohn M Hatcher, Ellen Weisberg, Taebo Sim, et al.
Statistics in Medicine|July 6, 2022
Controlled variable selection in Weibull mixture cure models for high-dimensional dataHan Fu, Deedra Nicolet, Krzysztof Mrózek, et al.
Blood|October 22, 2003
Fatal hepatic necrosis following imatinib mesylate therapyNancy U Lin, Stefanie Sarantopoulos, James R Stone, et al.
Blood Reviews|February 22, 2023
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDSStacey M Frumm, Shai Shimony, Richard M Stone, et al.
Journal of Oncology Practice|August 15, 2013
Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical centerBrett E Glotzbecker, Deborah S Yolin-Raley, Daniel J DeAngelo, et al.
Clinical Trials (London, England)|July 24, 2018
Application of multi-state models in cancer clinical trialsJennifer G Le-Rademacher, Ryan A Peterson, Terry M Therneau, et al.
Briefings in Bioinformatics|October 2, 2022
High-dimensional genomic feature selection with the ordered stereotype logit modelAnna Eames Seffernick, Krzysztof Mrózek, Deedra Nicolet, et al.
Blood Advances|June 8, 2019
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)Jun Yin, Betsy LaPlant, Geoffrey L Uy, et al.
Pageof 42